Reversing muscle relaxants in ICU patients
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests two medicines that help reverse the muscle-relaxing drugs given to patients on breathing tubes in the intensive care unit. The goal is to see which one works better and faster so patients can wake up sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years of age or older.
- You have a breathing tube placed in the intensive care unit.
- You do not have any condition that makes it hard to check your brain function.
- You do not have a muscle or nerve disease.
- You are not allergic to the study medicines (sugammadex or neostigmine).
- You are not taking toremifene, fusidic acid, or hormonal contraception.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing how well a drug called sugammadex works at different doses to reverse the effects of muscle relaxants used during surgery in babies and children under 2 years old. It aims to find the safest and most effective dose for this age group.
This study tests a domestic version of sugammadex sodium (a drug that reverses muscle relaxants) after lung surgery. It aims to see how well it works to help you wake up and recover from anesthesia.
This trial compares two medicines used at the end of anesthesia to help you wake up safely and breathe on your own in the recovery room (PACU). It may help find which option works better for people having certain abdominal surgeries.
This study compares a new muscle relaxant medication with a standard one to see how well they work for placing a breathing tube and maintaining muscle relaxation during surgery. It aims to find a safer or more effective option for patients undergoing general anesthesia.
This trial compares two muscle relaxants, rocuronium and cisatracurium, to see which causes fewer complications in people with chronic kidney disease (not on dialysis) who need general anesthesia. If you have kidney disease and are having surgery that requires a breathing tube, this study may help determine the safer drug for you.
This trial tests a new drug called HRS-9190 against a standard muscle relaxant (cisatracurium) given continuously through an IV during surgery. It aims to see if the new drug works as well and is safe for adults having planned surgery under general anesthesia.
Hear when a new Neuromuscular Blockade trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.